Ignite Creation Date:
2024-05-06 @ 3:01 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04500548
Status:
WITHDRAWN
Last Update Posted:
2022-09-10
First Post:
2020-08-04
Brief Title:
Testing the Combination of Two Immunotherapy Drugs Nivolumab and Ipilimumab in Children Adolescent and Young Adult Patients With RelapsedRefractory Cancers That Have an Increased Number of Genetic Changes The 3CI Study
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Constitutional Mismatch Repair Deficiency Syndrome |
| Hematopoietic and Lymphoid Cell Neoplasm |
| Lynch Syndrome |
| Recurrent Lymphoma |
| Recurrent Malignant Solid Neoplasm |
| Recurrent Neuroblastoma |
| Recurrent Primary Central Nervous System Neoplasm |
| Refractory Lymphoma |
| Refractory Malignant Solid Neoplasm |
| Refractory Neuroblastoma |
| Refractory Primary Central Nervous System Neoplasm |
| Xeroderma Pigmentosum |
Keywords: